EUVIMEDEUVIMED entdecken
Leserbrief

Hydroxychloroquine might reduce mortality in patients with systemic sclerosis

Eda Otman iD, Sercan Gucenmez iD, Dilek Solmaz iD, Servet Akar iD, Mustafa Ozmen iD

International Journal of Rheumatic Diseases · 2023

DOI: 10.1111/1756-185x.14670 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Rheumatic Diseases, 2023. Verfasst von Eda Otman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Scleroderma, Localized. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic sclerosis (SSc) is a devastating disease that has a profound impact on life expectancy, reflected by a standardised mortality ratio of 3,5. There is still limited data regarding the predictive factors for mortality in patients with SSc. Determining those factors could guide in disease management and follow up. 1 Objectives: We aimed to identify the predictive factors for death in SSc.

Methods

Patients

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicScleroderma, LocalizedHumansHydroxychloroquinePatients

Stichwörter der Autor:innen

hydroxychloroquinemortalitypredictorssclerodermasystemic sclerosis

Substanzen

Hydroxychloroquine

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey.

ORCID-Profile: Eda Otman, Sercan Gucenmez, Dilek Solmaz, Servet Akar, Mustafa Ozmen

Zitieren

APA

Otman, E., Gucenmez, S., Solmaz, D., Akar, S., & Ozmen, M. (2023). Hydroxychloroquine might reduce mortality in patients with systemic sclerosis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14670

Vancouver

Otman E, Gucenmez S, Solmaz D, Akar S, Ozmen M. Hydroxychloroquine might reduce mortality in patients with systemic sclerosis. International Journal of Rheumatic Diseases. 2023. doi:10.1111/1756-185x.14670

BibTeX
@article{Otman2023,
  author = {Otman, Eda and Gucenmez, Sercan and Solmaz, Dilek and Akar, Servet and Ozmen, Mustafa},
  title = {Hydroxychloroquine might reduce mortality in patients with systemic sclerosis},
  journal = {International Journal of Rheumatic Diseases},
  year = {2023},
  doi = {10.1111/1756-185x.14670}
}
Kostenlos starten →